USANA Health Sciences Inc. - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report (Form 10-Q) for USANA Health Sciences Inc. for the period ended September 28, 2002. USANA develops and manufactures nutritional, personal care, and weight management products distributed via a network marketing system. Operations span the United States, Canada, Australia, New Zealand, Hong Kong, Japan, and the United Kingdom, with new operations commencing in Taiwan in October 2002.
Key Financial Metrics
| Metric (in thousands) | Quarter Ended Sep 28, 2002 | Nine Months Ended Sep 28, 2002 |
|---|---|---|
| Net Sales | $34,787 | $95,477 |
| Gross Profit | $26,357 | $70,977 |
| Gross Margin | 75.8% | 74.3% |
| Net Earnings | $2,343 | $5,198 |
| Diluted EPS | $0.22 | $0.50 |
| Cash and Equivalents | $6,274 | $6,274 (Ending Balance) |
| Operating Cash Flow (9mo) | N/A | $11,793 |
| Total Debt (Current + Long-term) | $7,633 | $7,633 (Ending Balance) |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 18.6% for the quarter and 11.6% for the nine-month period compared to the prior year. Growth was driven by strong Associate enrollments (anticipating the Taiwan launch), new Japan market operations, and favorable foreign currency translation.
- Profitability: Net earnings surged 300% for the quarter and 235% for the nine-month period. Gross margins improved to 75.8% (quarter) and 74.3% (nine months) due to procurement efficiencies, economies of scale, and higher-margin sales in Japan.
- Expense Management: Selling, general, and administrative (SG&A) expenses decreased as a percentage of sales (26.2% for the quarter) despite absolute increases due to new market costs. Interest expense decreased significantly due to lower debt levels and interest rates.
- Balance Sheet: Cash and cash equivalents increased from $2.5 million to $6.3 million. The company reduced its line of credit usage from $4.1 million to $1.1 million and paid down long-term debt.
Outlook, Risks, and Management Commentary
- Guidance: Management expects the effective tax rate for fiscal 2002 to approximate 35%. Gross profit margins are expected to see modest improvements in the fourth quarter. SG&A expenses are expected to be higher in Q4 due to Taiwan operations.
- Share Repurchases: The company has repurchased and retired 958,000 shares for $6.9 million through November 4, 2002, under an authorized program.
- Operational Risks: A West Coast shipping work slowdown and subsequent lockout (beginning September 27, 2002) poses a risk to timely product delivery to Pacific Rim markets. While safety stock is maintained, prolonged delays could impact revenue timing or result in order cancellations.
- Market Risks: The company faces exposure to foreign currency fluctuations (46.2% of sales are international) and has no hedging instruments in place. There is also a risk regarding potential changes to U.S. tax benefits on foreign sales contested by the World Trade Organization.
- Personnel: John B. McCandless resigned as Chief Operating Officer on November 4, 2002; responsibilities have been reassigned with no immediate plans for replacement.
Investor Verification Checklist
- Verify the impact of the West Coast port lockout on Q4 revenue recognition and distribution costs.
- Monitor the sustainability of gross margin improvements given the mix of lower-margin sales aids and starter kits.
- Assess the progress and profitability of the new Taiwan market operations commencing in October 2002.
- Review the company's compliance with debt covenants under the $20 million credit facility.
- Track the effectiveness of the share repurchase program and its impact on diluted EPS.